Superworth

CareDx price to book ratio CDNA

Market value divided by the book value of the company's net assets, since 2014.

Today, Nov 2, 2026
9.7×
10-year median
4.5×
Against its 10-year history
71st
percentile: 0 is its lowest day, 100 its highest
10-year range
0.6× to 36.2×
Peer median
3.6×

CareDx's price to book ratio is 9.7× as of Nov 2, 2026.

That is above its ten-year median of 4.5×, higher than on 71% of days in the last ten years.

Over that time it ranged from 0.6× in Apr 2017 to 36.2× in Sep 2018.

The median for 10 diagnostics and research stocks of a similar size is 3.6×.

Price to book ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far9.7×2.7×9.8×
20253.2×1.7×4.8×
20244.1×1.1×6.6×
20231.6×0.7×2.0×
20221.4×1.4×4.8×
20215.1×4.7×16.4×
202013.3×6.0×15.2×
20199.3×8.6×27.7×
201820.6×11.6×36.2×
201711.0×0.6×11.2×
20161.6×1.5×4.0×
20152.2×1.4×2.3×
20142.0×2.0×2.1×

Against its peers

Companies in Medical - Diagnostics & Research nearest CareDx's size, closest first, today.

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on CareDx

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.